Impedimed Ltd (OTCPK:IPDQF)
$ 0.0421 0 (0%) Market Cap: 72.33 Mil Enterprise Value: 57.27 Mil PE Ratio: 0 PB Ratio: 4.21 GF Score: 0/100

Q3 2023 ImpediMed Ltd Activities Report Call Transcript

Apr 16, 2023 / 11:30PM GMT
Operator

Thank you for standing by, and welcome to the ImpediMed Limited Quarterly Results Conference Call and Investor presentation. (Operator Instructions) I would now like to hand the conference over to Mr. Rick Valencia, Managing Director and Chief Executive Officer. Please go ahead.

Richard P. Valencia
ImpediMed Limited - MD, CEO & Director

Thank you, Winnie, and welcome, everybody, to our third quarter 4C and investor presentation. We've got some good updates for you. We've got 3 key updates that we want to cover today.

First of all, as we talked about a few weeks ago, the NCCN survivorship guidelines were updated very favorably for us. And that has turned into a very transformative moment for the company in a number of ways, and we're going to get into a little bit more detail as to how after we give you a third quarter update in a few minutes.

We're also achieving significant momentum with payers in the U.S. We talked a bit about that, and I believe some folks were a bit frustrated that we couldn't give you a little bit more detail around

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot